40 Hz Masked Light: A new venture to slow the progression of Alzheimer’s Disease

Project description

Slowing down Alzheimer's disease with flashing light

Available treatments for Alzheimer's disease (AD) are ineffective and fail to halt progressive and irreversible brain damage. Recent evidence indicates that non-invasive flashing light can clear amyloid-beta, one of the key pathogenic hallmarks of AD, and offer neural protection. The EU-funded BRIGHT project will conduct a feasibility study for a novel flickering white light therapy that can stimulate the human visual receptors and processing cortex. The white light forms by combining different coloured LEDs and does not cause fatigue like stroboscopic light. The proposed intervention has the potential to delay disease onset, reduce prevalence and associated costs.

Fields of science

• medical and health sciences › health sciences › public and environmental health
• medical and health sciences › basic medicine › neurology › alzheimer
• engineering and technology › materials engineering › colors
• social sciences › economics and business › business and management › commerce

Programme(s)

• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-SMEInst-2018-2020-1
See other projects for this call

Funding Scheme

SME-1 - SME instrument phase 1

Coordinator

OPTOCEUTICS APS

Address

Diplomvej 381
2800 Kongens Lyngby
Denmark

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU contribution

€ 50 000